|
Age (years)
|
49 (41–56)
|
47 (40–55)
|
0.03
|
|
Male sex
|
812 (44.9%)
|
267 (76.5%)
|
< 0.001
|
|
Weight (kg)
|
72.0 (61.0–82.0)
|
84.0 (74.0–95.0)
|
< 0.001
|
|
Height (m)
|
1.68 (1.60–1.74)
|
1.73 (1.67–1.79)
|
< 0.001
|
|
BMI (kg/m2)
|
25.1 (22.6–28.1)
|
27.9 (25.4–30.9)
|
< 0.001
|
|
BMI class (NIH)
| | |
< 0.001
|
|
Underweight
|
19 (1.0%)
|
0 (0.0%)
| |
|
Normal
|
871 (48.1%)
|
66 (18.9%)
| |
|
Overweight
|
607 (33.5%)
|
170 (48.7%)
| |
|
Obesity class 1
|
230 (12.7%)
|
81 (23.2%)
| |
|
Obesity class 2
|
65 (3.6%)
|
28 (8.0%)
| |
|
Obesity class 3
|
18 (1.0%)
|
4 (1.1%)
| |
|
Fatty liver
|
637 (35.2%)
|
259 (74.2%)
|
< 0.001
|
|
Fatty liver degree
| | |
< 0.001
|
|
Light
|
428 (67.2%)
|
107 (41.3%)
| |
|
Moderate
|
151 (23.7%)
|
102 (39.4%)
| |
|
Severe
|
58 (9.1%)
|
50 (19.3%)
| |
|
Fatty liver type
| | |
< 0.001
|
|
None
|
1173 (64.8%)
|
90 (25.8%)
| |
|
NAFLD
|
407 (22.5%)
|
160 (45.8%)
| |
|
AFLD
|
230 (12.7%)
|
99 (28.4%)
| |
|
Waist circumference (cm)
|
100.0 (93.0–107.0)
|
105.0 (100.0–113.0)
|
< 0.001
|
|
Large waist circumference
|
1236 (68.3%)
|
259 (74.2%)
|
0.028
|
|
Glucose (mg/dl)
|
89 (83–96)
|
93 (87–102)
|
< 0.001
|
|
High fasting glucose
|
307 (17.0%)
|
109 (31.2%)
|
< 0.001
|
|
Triglycerides (mg/dl)
|
97 (68–139)
|
138 (98–206)
|
< 0.001
|
|
High triglycerides
|
405 (22.4%)
|
159 (45.6%)
|
< 0.001
|
|
Total cholesterol (mg/dl)
|
207 (184–234)
|
215 (192–240)
|
0.005
|
|
HDL cholesterol (mg/dl)
|
61 (51–73)
|
50 (44–61)
|
< 0.001
|
|
Low HDL
|
219 (12.1%)
|
64 (18.3%)
|
0.002
|
|
LDL cholesterol (mg/dl)
|
126 (104–150)
|
138 (117–159)
|
< 0.001
|
|
Systolic blood pressure (mm Hg)
|
125 (120–140)
|
130 (120–140)
|
< 0.001
|
|
Diastolic blood pressure (mm Hg)
|
80 (80–90)
|
85 (80–90)
|
< 0.001
|
|
High blood pressure
|
1053 (58.2%)
|
270 (77.4%)
|
< 0.001
|
|
Metabolic syndrome
|
444 (24.5%)
|
171 (49.0%)
|
< 0.001
|
|
Metabolic syndrome score
| | |
< 0.001
|
|
0
|
216 (11.9%)
|
19 (5.4%)
| |
|
1
|
595 (32.9%)
|
59 (16.9%)
| |
|
2
|
555 (30.7%)
|
100 (28.7%)
| |
|
3
|
294 (16.2%)
|
97 (27.8%)
| |
|
4
|
117 (6.5%)
|
59 (16.9%)
| |
|
5
|
33 (1.8%)
|
15 (4.3%)
| |
|
ALT (U/l)
|
20 (15–26)
|
50 (44–63)
|
< 0.001
|
|
AST (U/l)
|
20 (18–24)
|
33 (29–41)
|
< 0.001
|
|
GGT (U/l)
|
17 (12–26)
|
42 (27–69)
|
< 0.001
|
|
Total bilirubin (mg/dl)
|
0.60 (0.40–0.81)
|
0.62 (0.49–0.90)
|
0.003
|
|
Alcohol intake (alcohol units/day)
|
2 (0–4)
|
3 (1–5)
|
< 0.001
|
|
Wine intake (alcohol units/day)
|
2 (0–2)
|
2 (1–3)
|
< 0.001
|
|
Beer intake (alcohol units/day)
|
0 (0–1)
|
0 (0–1)
|
0.52
|
|
Liquor intake (alcohol units/day)
|
0 (0–0)
|
0 (0–1)
|
< 0.001
|
